Literature DB >> 12908576

Severely sustained vomiting as the main symptom in a man with thyrotoxicosis.

Peter Chen1, Hua-Fen Chen, So-Wan Tan, Mei-Chin Su, Kam-Wing Ng, Chaw-Fung Jiang.   

Abstract

Thyrotoxicosis has a variety of presentations. Vomiting as a main presenting symptom of thyrotoxicosis is uncommon. We report a 40-year-old male with thyrotoxicosis who presented with sustained vomiting as the main symptom. He also had weight loss, about 10 kg over this 20-day period, and dizziness, particularly in the upright position. Esophagogastroduodenoscopy and abdominal ultrasonography were negative. Laboratory data were unremarkable except serum T4 of 21.2 microg/dl, T3 of 574 ng/dl and TSH < 0.03 microIU/ml. The patient's serum microsomal antibody was positive at a titer of 1:409,600, but serum thyroglogulin antibody was negative at a titer of less than 1:100. The symptoms improved after adminstroction of propylthyrouracil and propranol. A total of 31 such cases have been reported in English literature. The mean age of the patients was 46 +/- 14 year with a range of 19 to 68 years. Only 4 patients, including ours, were male. Weight loss was found in about half of them and might be an important clue. Thyrotoxicosis should be considered in differential diagnosis of unexplained vomiting.

Entities:  

Mesh:

Year:  2003        PMID: 12908576

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  3 in total

1.  Case Report: Recurrent severe vomiting due to hyperthyroidism.

Authors:  Li-ying Chen; Bo Zhou; Zhou-wen Chen; Li-zheng Fang
Journal:  J Zhejiang Univ Sci B       Date:  2010-03       Impact factor: 3.066

2.  Possible association between thyroid autoimmunity and Menière's disease.

Authors:  B Fattori; A Nacci; A Dardano; I Dallan; M Grosso; C Traino; V Mancini; F Ursino; F Monzani
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

Review 3.  Medical and Nonstroke Neurologic Causes of Acute, Continuous Vestibular Symptoms.

Authors:  Jonathan A Edlow; David E Newman-Toker
Journal:  Neurol Clin       Date:  2015-08       Impact factor: 3.787

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.